How to Get Trazodone in Texas: Telehealth, Prescriptions, and Pharmacy Options

How to Get Trazodone in Texas
At a glance
- Prescription required / Schedule: Non-scheduled, prescription-only
- Texas telehealth prescribing: Fully permitted under TX Occ. Code §111
- Who can prescribe: MD, DO, NP (with prescriptive authority), PA (with delegation)
- Standard dose for insomnia: 25 to 100 mg oral tablet at bedtime
- Standard dose for depression: 150 to 400 mg/day in divided doses
- Average retail cash price (generic, 30 tabs): $4 to $15
- Texas Medicaid coverage: Not covered for depression or off-label insomnia
- Commercial insurance tier: Typically Tier 1 generic
- 503A compounding in Texas: Available under Texas State Board of Pharmacy oversight
- Time from telehealth visit to pharmacy pickup: Often same day
Texas Telehealth Rules for Trazodone Prescriptions
Any Texas-licensed prescriber can order trazodone through a synchronous audio-video telehealth visit, provided a valid provider-patient relationship is established during that encounter. Texas Occupational Code Chapter 111 governs telehealth practice standards and does not restrict non-controlled medications like trazodone from remote prescribing. No in-person visit is required before the first prescription.
Trazodone is not a controlled substance under the federal Controlled Substances Act or the Texas Controlled Substances Act. This matters because Texas imposes additional telehealth restrictions on Schedule II through V drugs that simply do not apply here. A prescriber can evaluate symptoms, confirm the indication, and transmit an electronic prescription to any Texas pharmacy during a single telehealth encounter.
Multiple national and Texas-based telehealth platforms now include trazodone in their formularies for both depression and off-label insomnia. Visit times typically run 15 to 30 minutes. The FDA-approved labeling for trazodone lists major depressive disorder as the approved indication, while off-label use for insomnia accounts for the majority of prescriptions written nationally. A 2014 analysis published in the Journal of Clinical Psychiatry found trazodone was the most commonly prescribed medication for insomnia in the United States, ahead of all FDA-approved hypnotics [1].
Who Can Prescribe Trazodone in Texas
Physicians (MD and DO), nurse practitioners with prescriptive authority, and physician assistants with a prescriptive delegation agreement can all prescribe trazodone in Texas. The scope is broad. NPs in Texas gained independent prescriptive authority for non-controlled substances in specific practice settings, though many still operate under collaborative agreements depending on their practice type.
PAs must maintain a signed prescriptive authority agreement with a supervising physician. The agreement must specify the categories of drugs the PA can prescribe, and trazodone falls under the general non-controlled antidepressant category. Texas Medical Board Rule 193.6 governs these delegation agreements.
Psychiatrists and sleep medicine specialists prescribe trazodone most frequently for their respective indications, but family medicine and internal medicine providers write the majority of trazodone prescriptions by volume. If you are seeking trazodone specifically for insomnia, a primary care provider is a reasonable starting point. Referral to a sleep specialist becomes appropriate when insomnia persists beyond 12 weeks of treatment or when a comorbid sleep disorder like obstructive sleep apnea is suspected [2].
What Labs Your Provider May Order Before Prescribing
There is no mandatory lab panel required before starting trazodone, but most clinicians will order baseline studies for clinical decision-making. A complete metabolic panel (CMP) evaluates liver and kidney function, both relevant to trazodone metabolism. Trazodone undergoes hepatic metabolism primarily through CYP3A4, and dose adjustments may be necessary in patients with significant hepatic impairment [3].
A thyroid-stimulating hormone (TSH) level is standard practice when a patient presents with both depressive symptoms and insomnia, since hypothyroidism can cause both. An electrocardiogram (ECG) may be ordered in patients over 65 or those with known cardiac disease, because trazodone carries a low but documented risk of QT prolongation at higher doses [4]. The American Heart Association recommends ECG screening in older adults starting QT-prolonging medications.
For patients being evaluated for depression specifically, the PHQ-9 questionnaire serves as both a diagnostic aid and a treatment-response tracker. Expect your provider to administer this at baseline and at follow-up visits.
Insurance Coverage and Cost in Texas
Generic trazodone is one of the least expensive antidepressants on the market. Cash prices at major Texas pharmacy chains (CVS, Walgreens, H-E-B Pharmacy, Walmart) range from $4 to $15 for a 30-day supply of 50 mg or 100 mg tablets. H-E-B Pharmacy includes trazodone on its discount generic list in many locations.
Commercial insurers in Texas (Blue Cross Blue Shield of Texas, Aetna, UnitedHealthcare, Cigna) almost universally place generic trazodone on Tier 1, resulting in copays between $0 and $10. Prior authorization is rarely required for the immediate-release tablet formulation.
Texas Medicaid presents a different picture. The Texas Medicaid preferred drug list does not cover trazodone for depression or off-label insomnia. Coverage is limited to type 2 diabetes indications only, which excludes the vast majority of trazodone use cases. Patients on Texas Medicaid who need trazodone for depression or insomnia may need to pay cash price or work with their prescriber to submit a non-preferred drug authorization (NPDA) request. The NPDA process requires documentation of clinical necessity and prior trial-and-failure of at least one preferred alternative.
The extended-release formulation (trazodone ER, brand Oleptro) costs significantly more, often $200 to $400 per month without insurance, and is more likely to require prior authorization even from commercial plans. For most patients, the immediate-release generic at bedtime achieves equivalent outcomes for insomnia at a fraction of the cost.
How to Fill Your Trazodone Prescription at a Texas Pharmacy
Once your prescriber transmits the electronic prescription, any licensed Texas pharmacy can dispense it. Most retail pharmacies stock generic trazodone and can fill the prescription within one to four hours. Same-day pickup is the norm for this medication.
Mail-order pharmacy is another option. Express Scripts, CVS Caremark, and OptumRx all include trazodone in their mail-order formularies, typically offering 90-day supplies at reduced copays. Delivery to a Texas address usually takes 5 to 7 business days for standard shipping.
For patients transferring a trazodone prescription from another state, the process is straightforward. Texas pharmacies can accept prescription transfers from any U.S. state for non-controlled medications. Your new Texas pharmacy contacts the originating pharmacy directly to process the transfer. No additional prescriber authorization is needed unless the prescription has expired or has no remaining refills.
Texas 503A compounding pharmacies can also prepare trazodone in custom formulations (liquid suspensions, alternative dosage strengths) when a prescriber determines a compounded preparation is medically necessary. The Texas State Board of Pharmacy regulates 503A facilities and requires them to compound in accordance with USP standards. Compounded trazodone is not typically necessary, since the commercially available tablets cover the standard dose range, but it can be useful for patients who cannot swallow tablets or who need precise sub-25 mg dosing for sleep.
Clinical Evidence for Trazodone in Insomnia
Trazodone's use for insomnia rests on decades of clinical experience and a smaller evidence base than its use for depression. The Mendelson 2005 study published in the Journal of Clinical Psychiatry evaluated trazodone 50 mg for primary insomnia in a randomized, double-blind, placebo-controlled trial (N=306). Trazodone significantly improved subjective sleep quality during the first two weeks of treatment, though the benefit diminished by week six compared to placebo [1].
A meta-analysis published in the Annals of Internal Medicine examining pharmacologic treatments for insomnia disorder found that trazodone showed moderate evidence for short-term improvement in sleep onset latency and total sleep time, with a lower risk of next-day sedation compared to benzodiazepine receptor agonists [5]. The American Academy of Sleep Medicine (AASM) 2017 clinical practice guideline does not include trazodone among its recommended pharmacologic treatments for chronic insomnia, citing insufficient evidence for a formal recommendation. The AASM does recommend cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment [6].
Despite the AASM's position, trazodone remains the most prescribed off-label sleep medication in the United States. Clinicians favor it for several practical reasons: it is non-addictive, carries no DEA scheduling restrictions, costs very little, and treats comorbid depression when present. "Trazodone at low doses fills a real clinical niche for patients who have insomnia with comorbid depression or anxiety, particularly when we want to avoid controlled substances," notes the 2017 AASM position statement discussion [6].
A retrospective cohort study in JAMA Internal Medicine (N=423,278) analyzed fall risk among older adults prescribed various sleep medications and found trazodone was associated with a lower adjusted odds ratio for falls (OR 1.12; 95% CI 1.08 to 1.16) compared with benzodiazepines (OR 1.42; 95% CI 1.38 to 1.46) and Z-drugs like zolpidem (OR 1.37; 95% CI 1.34 to 1.40) [7]. This relative safety profile contributes to its popularity among geriatricians in Texas and nationally.
Trazodone Dosing: Depression vs. Insomnia
The dosing ranges differ substantially between the two indications. For depression, the FDA-approved starting dose is 150 mg/day in divided doses, titrated upward in 50 mg increments every 3 to 4 days. The maximum recommended dose is 400 mg/day for outpatients and 600 mg/day for inpatients [3].
For insomnia, doses are much lower. Most clinicians start at 25 to 50 mg taken 30 minutes before bedtime. Some patients respond to doses as low as 12.5 mg (half of a scored 25 mg tablet). Doses above 100 mg for insomnia alone are uncommon and increase the risk of next-day grogginess, orthostatic hypotension, and the rare but serious side effect of priapism [3].
The half-life of trazodone is 5 to 9 hours, which makes it well-suited for sleep maintenance but occasionally causes morning sedation in slow metabolizers. Patients who report persistent morning drowsiness can try taking the dose 1 to 2 hours earlier in the evening or reducing the dose by 25%.
Prior Authorization in Texas: When It Applies
Prior authorization for generic immediate-release trazodone is uncommon with commercial insurance. It becomes relevant in two situations: Texas Medicaid coverage requests and extended-release formulation requests.
For Texas Medicaid, the prescriber must submit a non-preferred drug authorization through the Texas Vendor Drug Program. Required documentation includes the patient's diagnosis (ICD-10 code), a list of preferred alternatives already tried and failed, the rationale for trazodone specifically, and supporting clinical notes. The review timeline is 24 hours for standard requests and 4 hours for urgent requests.
For commercial insurers requiring prior authorization on the extended-release formulation, the typical criteria include documented trial and failure (or intolerance) of immediate-release trazodone. Most plans approve the ER formulation only after the IR version proves inadequate.
Documentation your provider should have ready: office visit notes, PHQ-9 scores, a medication history showing alternatives attempted, and any relevant lab results. Fax-based prior authorization remains the most common submission method in Texas, though electronic prior authorization (ePA) adoption is increasing among major insurers.
Safety Considerations and Drug Interactions
Trazodone carries a boxed warning from the FDA for increased suicidality risk in children, adolescents, and young adults under 25 with major depressive disorder. This warning applies to all antidepressants and requires close monitoring during the first 4 weeks of treatment and after dose changes [3].
The most clinically significant drug interaction involves monoamine oxidase inhibitors (MAOIs). Concurrent use of trazodone with MAOIs can precipitate serotonin syndrome, a potentially fatal condition characterized by hyperthermia, rigidity, and autonomic instability. A washout period of at least 14 days is required when switching between trazodone and an MAOI [3].
CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) increase trazodone plasma levels and may require dose reduction. CYP3A4 inducers (carbamazepine, phenytoin) decrease trazodone levels and may require dose increases. The NIH drug interaction database provides a comprehensive interaction list.
Priapism is a rare (estimated incidence 1 in 6,000 to 1 in 8,000 male patients) but serious adverse effect requiring emergency intervention if an erection persists beyond 4 hours [8]. All male patients starting trazodone should be counseled on this risk and instructed to seek emergency care if it occurs.
Orthostatic hypotension is more common, particularly in older adults and patients taking antihypertensives. Blood pressure monitoring at follow-up visits is standard practice. The risk increases with doses above 150 mg/day.
Timeline: From Visit to First Dose
The typical timeline for a Texas patient obtaining trazodone through telehealth is compressed compared to most medications. A new-patient telehealth visit can often be scheduled within 24 to 72 hours. The visit itself runs 15 to 30 minutes. Electronic prescriptions transmit to the pharmacy in minutes. Pharmacy fill time for a stocked generic is 1 to 4 hours.
For many patients, the entire process from scheduling a telehealth appointment to picking up trazodone at a Texas pharmacy takes under 48 hours. Patients using mail-order pharmacy should add 5 to 7 business days for shipping. Patients requiring prior authorization through Texas Medicaid should budget an additional 1 to 3 business days for standard review.
Frequently asked questions
›How do I get a trazodone prescription in Texas?
›What labs are needed before trazodone in Texas?
›Are there telehealth providers in Texas prescribing trazodone?
›How long until I receive trazodone in Texas?
›Can I transfer a trazodone prescription to Texas?
›Are 503A pharmacies in Texas licensed to ship trazodone?
›Who can prescribe trazodone in Texas: MD vs NP vs PA?
›What documentation does prior authorization require in Texas?
›Is trazodone a controlled substance in Texas?
›Does Texas Medicaid cover trazodone for insomnia?
›What is the typical starting dose of trazodone for sleep?
›Can I get trazodone at H-E-B Pharmacy in Texas?
References
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487-504. https://pubmed.ncbi.nlm.nih.gov/18853708/
- Trazodone hydrochloride prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207
- Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013;54(1):1-13. https://pubmed.ncbi.nlm.nih.gov/23295003/
- Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016;165(2):103-112. https://pubmed.ncbi.nlm.nih.gov/27136278/
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28162809/
- Berry SD, Lee Y, Cai S, Dore DD. Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med. 2013;173(9):754-761. https://pubmed.ncbi.nlm.nih.gov/23460082/
- Warner MD, Peabody CA, Whiteford HA, Hollister LE. Trazodone and priapism. J Clin Psychiatry. 1987;48(6):244-245. https://pubmed.ncbi.nlm.nih.gov/3584085/